Myriad Genetics, Inc. · NASDAQ:MYGN
Glenview Capital Management, LLC's stake in Myriad Genetics, Inc. fell below 5% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Glenview Capital Management, LLC's stake in Myriad Genetics, Inc. fell below 5%, 0 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| GLENVIEW CAPITAL MANAGEMENT, LLC | 0% | 0 |
| ROBBINS LARRY | 0% | 0 |
Source
Related
- Myriad Genetics, Inc.
- Glenview Capital Management, LLC
- Myriad Genetics, Inc. shareholders
- Schedule 13G · Glenview Capital Management, LLC · Jan 13, 2026
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026